196 related articles for article (PubMed ID: 15580028)
1. Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars.
Phan TT; Lim IJ; Chan SY; Tan EK; Lee ST; Longaker MT
J Trauma; 2004 Nov; 57(5):1032-7. PubMed ID: 15580028
[TBL] [Abstract][Full Text] [Related]
2. Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts.
Tang B; Zhu B; Liang Y; Bi L; Hu Z; Chen B; Zhang K; Zhu J
Arch Dermatol Res; 2011 Oct; 303(8):563-72. PubMed ID: 21240513
[TBL] [Abstract][Full Text] [Related]
3. FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
Wu CS; Wu PH; Fang AH; Lan CC
Br J Dermatol; 2012 Sep; 167(3):532-41. PubMed ID: 22540338
[TBL] [Abstract][Full Text] [Related]
4. Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions.
Phan TT; Lim IJ; Aalami O; Lorget F; Khoo A; Tan EK; Mukhopadhyay A; Longaker MT
J Pathol; 2005 Oct; 207(2):232-42. PubMed ID: 16052471
[TBL] [Abstract][Full Text] [Related]
5. Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids.
Phan TT; See P; Tran E; Nguyen TT; Chan SY; Lee ST; Huynh H
Br J Dermatol; 2003 Mar; 148(3):544-52. PubMed ID: 12653748
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of transforming growth factor-beta receptors I and II and activation of Smad 3 in keloid fibroblasts.
Chin GS; Liu W; Peled Z; Lee TY; Steinbrech DS; Hsu M; Longaker MT
Plast Reconstr Surg; 2001 Aug; 108(2):423-9. PubMed ID: 11496185
[TBL] [Abstract][Full Text] [Related]
7. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
8. Comparison of transforming growth factor-beta/Smad signaling between normal dermal fibroblasts and fibroblasts derived from central and peripheral areas of keloid lesions.
Tsujita-Kyutoku M; Uehara N; Matsuoka Y; Kyutoku S; Ogawa Y; Tsubura A
In Vivo; 2005; 19(6):959-63. PubMed ID: 16277007
[TBL] [Abstract][Full Text] [Related]
9. Dietary compounds inhibit proliferation and contraction of keloid and hypertrophic scar-derived fibroblasts in vitro: therapeutic implication for excessive scarring.
Phan TT; Sun L; Bay BH; Chan SY; Lee ST
J Trauma; 2003 Jun; 54(6):1212-24. PubMed ID: 12813346
[TBL] [Abstract][Full Text] [Related]
10. Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Ma HL; Zhao XF; Chen GZ; Fang RH; Zhang FR
Biomed Pharmacother; 2016 Oct; 83():1016-1021. PubMed ID: 27525969
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
[TBL] [Abstract][Full Text] [Related]
12. Oxymatrine inhibits collagen synthesis in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.
Fan DL; Zhao WJ; Wang YX; Han SY; Guo S
Int J Dermatol; 2012 Apr; 51(4):463-72. PubMed ID: 22435440
[TBL] [Abstract][Full Text] [Related]
13. DKK3 regulates cell proliferation, apoptosis and collagen synthesis in keloid fibroblasts via TGF-β1/Smad signaling pathway.
Li Y; Liu H; Liang Y; Peng P; Ma X; Zhang X
Biomed Pharmacother; 2017 Jul; 91():174-180. PubMed ID: 28458155
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib exerts an anti-keloid activity by antagonizing TGF-β/Smad and MAPK/ERK signaling pathways.
Wang W; Qu M; Xu L; Wu X; Gao Z; Gu T; Zhang W; Ding X; Liu W; Chen YL
J Mol Med (Berl); 2016 Oct; 94(10):1181-1194. PubMed ID: 27339758
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of IRF3 inhibits extracellular matrix expression in keloid fibroblasts.
Zhang Y; Zhang L; Lin XH; Li ZM; Zhang QY
Biomed Pharmacother; 2017 Apr; 88():1064-1068. PubMed ID: 28192879
[TBL] [Abstract][Full Text] [Related]
16. [Effect of the methylation enzyme inhibitors of 5-aza-2-deoxycytidine on the TGF-beta/smad signal transduction pathway in human keloid fibroblasts].
Zou QP; Yang E; Zhang HS
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):285-9. PubMed ID: 24228511
[TBL] [Abstract][Full Text] [Related]
17. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic effect of interleukin-10 in keloid fibroblasts by suppression of TGF-β/Smad pathway.
Shi CK; Zhao YP; Ge P; Huang GB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):9085-9092. PubMed ID: 31696499
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CR6-interacting factor 1 suppresses keloid fibroblast growth via the TGF-β/Smad signaling pathway.
Nagar H; Kim S; Lee I; Kim S; Choi SJ; Piao S; Jeon BH; Oh SH; Kim CS
Sci Rep; 2021 Jan; 11(1):500. PubMed ID: 33436666
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of type I collagen expression in silibinin-treated human skin fibroblasts by blocking the activation of Smad2/3-dependent signaling pathways: potential therapeutic use in the chemoprevention of keloids.
Cho JW; Il KJ; Lee KS
Int J Mol Med; 2013 May; 31(5):1148-52. PubMed ID: 23503720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
